WASHINGTON, Sept. 21, 2023 /PRNewswire/ — The American Council of Cannabis Medicine (ACCM) expressed its unwavering support for the Health and Human Services (HHS) recommendation to reclassify cannabis from a Schedule I to a Schedule III controlled substance. As a next step, the ACCM…
